Auteurs
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Auteurs » - entrée « Zahir Amoura »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Zahi A. Fayad < Zahir Amoura < Zahit Ta  Facettes :

List of bibliographic references indexed by Zahir Amoura

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000192 (2021) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.
000D10 (2020) Alexis Mathian [France] ; Zahir Amoura [France]Response to: Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al.
000D11 (2020) Alexis Mathian [France] ; Marc Pineton De Chambrun [France] ; Alain Combes [France] ; Zahir Amoura [France]Response to: 'Presence of anti-phospholipid antibodies in COVID-19: a case series study' by Amezcua-Guerra et al.
000D12 (2020) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace et al.
000D13 (2020) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak' by Holubar et al.
000D14 (2020) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Implications of SARS-CoV-2 infection for patients with rheumatic disease' by Lin et al.
000D15 (2020) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India' by Goyal et al.
000D18 (2020) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Exacerbation of immune thrombocytopaenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo et al.
000D21 (2020) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey' by Plüß et al.
000D23 (2020) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh et al.
000D24 (2020) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian et al' by Notz et al.
000D28 (2020) Alexis Mathian [France] ; Zahir Amoura [France]Response to 'Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic' by Chuah et al.
001571 (2020) Alexis Mathian [France] ; Matthieu Mahevas [France] ; Julien Rohmer [France] ; Mathilde Roumier [France] ; Fleur Cohen-Aubart [France] ; Blanca Amador-Borrero [France] ; Audrey Barrelet [France] ; Cecile Chauvet [France] ; Thibaud Chazal [France] ; Michel Delahousse [France] ; Mathilde Devaux [France] ; Romain Euvrard [France] ; Jehane Fadlallah [France] ; Nans Florens [France] ; Julien Haroche [France] ; Miguel Hié [France] ; Laurent Juillard [France] ; Raphael Lhote [France] ; Thibault Maillet [France] ; Gaelle Richard-Colmant [France] ; Jean Baptiste Palluy [France] ; Micheline Pha [France] ; Laurent Perard [France] ; Philippe Remy [France] ; Etienne Rivière [France] ; Damien Sène [France] ; Pascal Sève [France] ; Capucine Morélot-Panzini [France] ; Jean-François Viallard [France] ; Jean-Simon Virot [France] ; Neila Benameur [France] ; Noël Zahr [France] ; Hans Yssel [France] ; Bertrand Godeau [France] ; Zahir Amoura [France]Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Zahir Amoura" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Zahir Amoura" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Zahir Amoura
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021